Program Description
Gout is the most common form
of chronic, inflammatory arthritis in the US, affecting approximately 9.2
million adults, with prevalence continuing to rise alongside obesity,
hypertension, chronic kidney disease, and other metabolic comorbidities.
Treatment typically involves urate-lowering therapies, yet many patients remain
undertreated with therapies that fail to achieve target levels of serum urate.
Uncontrolled gout leads to recurrent flares, chronic joint damage, and
diminished quality of life. While emerging therapies offer new treatment
strategies for patients with inadequately controlled or treatment-resistant
disease, gaps in adherence and limited patient counseling remain key barriers
to optimal outcomes. This activity will focus on the pharmacist’s role in
supporting treatment adherence and counseling patients on therapy options and
access, with strategies tailored specifically to the challenges of gout
management. The webinar will examine guideline-based management strategies,
clinical applications of novel agents, and patient-centered approaches for
pharmacists to improve outcomes in patients with gout.
Target Audience: Community Pharmacist, Retail
Pharmacist
Type of Activity: Application
Release date: November 21, 2025
Expiration date: November 21. 2026
Learner level: Foundational, Intermediate
Time to complete activity: 1.0 hour
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Explain the epidemiology, risk factors, and comorbidities associated with gout, including key contributors to disease burden
- Analyze the potential clinical applications of next-generation therapies for patients with inadequately controlled or treatment-resistant gout
- Apply patient-centered strategies to support shared decision-making and treatment adherence in patients with gout
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here